Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters











Database
Language
Publication year range
2.
Ital J Pediatr ; 50(1): 118, 2024 Jun 20.
Article in English | MEDLINE | ID: mdl-38902744

ABSTRACT

Food supplements are defined as foodstuffs the purpose of which is to supplement the normal diet and which are concentrated sources of nutrients or other substances with a nutritional or physiological effect, often referred to as nutraceuticals, may exert benefit to the human body. Their use is increasing worldwide, including Europe and in Italy. However, some doctors are skeptical about their effectiveness and safety. This reluctance may depend on poor knowledge of the mechanisms of action and clinical evidence in literature. The Italian Society of Pediatric Allergy and Immunology (SIAIP) promoted the institution of an ad hoc Committee. The first initiative performed by this Committee was the administration of a questionnaire to the members of SIAIP.The results of this survey provided interesting results. Most pediatricians know the food supplement concept but frequently need help understanding the mechanisms of action. Most prescribe food supplements, mainly for preventing infections or enhancing immune defense. In addition, they prefer to use food supplements as cycles or add-on therapy. Finally, most participants like to attend events on this issue and contribute to new evidence through trials.In conclusion, this survey underscores the relevance of food supplement issues and attests to interest in this topic. However, there is a need to provide information and promote studies on this matter.


Subject(s)
Dietary Supplements , Societies, Medical , Humans , Italy , Surveys and Questionnaires , Attitude of Health Personnel , Child , Allergy and Immunology , Pediatrics , Practice Patterns, Physicians' , Male , Pediatricians , Female
3.
Nutrients ; 16(12)2024 Jun 17.
Article in English | MEDLINE | ID: mdl-38931261

ABSTRACT

The prevalence of allergic diseases has dramatically increased among children in recent decades. These conditions significantly impact the quality of life of allergic children and their families. Lactoferrin, a multifunctional glycoprotein found in various biological fluids, is emerging as a promising immunomodulatory agent that can potentially alleviate allergic diseases in children. Lactoferrin's multifaceted properties make it a compelling candidate for managing these conditions. Firstly, lactoferrin exhibits potent anti-inflammatory and antioxidant activities, which can mitigate the chronic inflammation characteristic of allergic diseases. Secondly, its iron-binding capabilities may help regulate the iron balance in allergic children, potentially influencing the severity of their symptoms. Lactoferrin also demonstrates antimicrobial properties, making it beneficial in preventing secondary infections often associated with respiratory allergies. Furthermore, its ability to modulate the immune response and regulate inflammatory pathways suggests its potential as an immune-balancing agent. This review of the current literature emphasises the need for further research to elucidate the precise roles of lactoferrin in allergic diseases. Harnessing the immunomodulatory potential of lactoferrin could provide a novel add-on approach to managing allergic diseases in children, offering hope for improved outcomes and an enhanced quality of life for paediatric patients and their families. As lactoferrin continues to capture the attention of researchers, its properties and diverse applications make it an intriguing subject of study with a rich history and a promising future.


Subject(s)
Hypersensitivity , Lactoferrin , Respiratory Tract Diseases , Child , Humans , Anti-Inflammatory Agents/therapeutic use , Antioxidants/therapeutic use , Hypersensitivity/drug therapy , Lactoferrin/therapeutic use , Quality of Life , Respiratory Tract Diseases/drug therapy
4.
Ital J Pediatr ; 46(1): 18, 2020 Feb 10.
Article in English | MEDLINE | ID: mdl-32039733

ABSTRACT

The upper airways (UA) should be considered as a functional unit. Current functional anatomy divides URT in three, mutually dependent, "junction boxes": i) the ostio-meatal complex (OMC), ii) the spheno-ethmoidal recess (SER), and iii) the rhinopharynx (RP). Correct ventilation and effective mucociliary clearance of these sites significantly affect the healthy physiology of the entire respiratory system. The OMC, SER, and RP obstruction is the first pathogenic step in the inflammatory/infectious cascade of UA disorders. The inflammation of the respiratory mucosa is the main pathogenic factor for airway obstruction. Moreover, bacterial biofilm (a strategy modality of bacterial survival) is an important local cause of systemic antibiotic ineffectiveness, recurrent infections, and antibiotic resistance. Health microbiota guarantees UA wellness; on the contrary, dysbiosis promotes and worsens UA infections. Allergy, namely type 2 inflammation, is a common cause of UA obstruction such as promoting in turn infections. Fiberoptic endoscopy is a mandatory diagnostic tool in clinical practice. Nasal cytology, mainly concerning flow cytometry, allows defining rhinitis phenotypes so allowing a precision medicine approach. Several conventional therapeutic approaches are available, but efficacy and safety should be ever properly considered before the prescription. Also, complementary medicine plays a fruitful role in the management of UA diseases. National and real-world studies are reported and discussed as they may be useful in daily clinical practice.


Subject(s)
Hypersensitivity/epidemiology , Inflammation/epidemiology , Rhinitis/epidemiology , Endoscopy/methods , Global Health , Humans , Hypersensitivity/diagnosis , Inflammation/diagnosis , Morbidity , Rhinitis/diagnosis
5.
Eur J Pediatr ; 174(1): 91-6, 2015 Jan.
Article in English | MEDLINE | ID: mdl-24997847

ABSTRACT

UNLABELLED: The aim of the present study was to investigate the current approach of Italian general pediatricians to children with gastroesophageal reflux (GER) symptoms, evaluating the implementation of the 2009 North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN)-European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) guidelines. One hundred randomly identified Italian general pediatricians were asked to complete a case report-structured questionnaire investigating their approach to infants, children, and adolescents with symptoms suggestive of GER. Only 2 % of them showed complete adherence to the guidelines. Thirty-nine percent of them diagnosed GER disease based on clinical symptoms, irrespective of the age of the child; 56 % prescribed proton pump inhibitors (PPIs) in infants with unexplained crying and/or distressed behavior and 38 % in infants with uncomplicated recurrent regurgitation and vomiting; 57 % prescribed PPIs in children younger than 8-12 years of age with vomiting and heartburn, without specific testing; and 54 % discontinued PPI therapy abruptly. The overall rate of pediatricians over-prescribing PPIs was 79 %. CONCLUSION: According to our findings, most Italian general pediatricians do not seem to follow the recommendations of the 2009 NASPGHAN-ESPGHAN reflux guidelines and often prescribe PPIs despite a lack of efficacy for the symptoms being treated. We are well aware that the guidelines address the average situation and that the evaluation of individual patients may frequently reveal reasons for opening criteria for exceptions. Nevertheless, the over-diagnosis of gastroesophageal reflux disease (GERD) places undue burden on both families and national health system which has not been impacted by the publication of international guidelines.


Subject(s)
Gastroesophageal Reflux/diagnosis , Pediatrics/statistics & numerical data , Practice Guidelines as Topic/standards , Practice Patterns, Physicians'/statistics & numerical data , Adolescent , Child , Gastroesophageal Reflux/drug therapy , Guideline Adherence , Health Surveys , Humans , Infant, Newborn , Italy , Prospective Studies , Surveys and Questionnaires
6.
J Clin Gastroenterol ; 44 Suppl 1: S22-5, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20562632

ABSTRACT

Food allergy is a frequent problem in childhood and its prevalence is increasing. In most cases food allergy is an IgE-mediated hypersensitivity response that cause skin reactions as urticaria. Subacute or chronic disorders have generally a not IgE mediated mechanism. Milk is the most common food allergen in USA and UK followed by egg, peanut and walnuts. Sensitization to milk or egg in infancy is associated with an increased risk to develop house dust mite sensitization and asthma later in childhood. Commensal gut flora play a role in induction of oral tolerance and the importance of the intestinal microbiota in the development of food allergy is essential in early ages, when the mucosal barrier and immune system are still immature. Probiotics interact with the mucosal immune system by the same pathways as commensal bacteria. Recent study show that probiotic bacteria induced in vivo increased plasma levels IL-10 and total IgA in children with allergic predisposition. Many clinical studies reporting significant benefits by probiotics supplementation in food allergy prevention and management but not everyone agree on their effectiveness. These differences are probably related to differences in selected populations and in probiotic strains used.


Subject(s)
Food Hypersensitivity/therapy , Intestines/microbiology , Probiotics/therapeutic use , Age Factors , Child , Child, Preschool , Food Hypersensitivity/classification , Food Hypersensitivity/immunology , Food Hypersensitivity/microbiology , Humans , Immune Tolerance , Immunity, Mucosal , Immunoglobulin A/blood , Interleukin-10/blood , Intestines/immunology , Treatment Outcome
7.
J Clin Gastroenterol ; 42 Suppl 3 Pt 2: S205-8, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18685512

ABSTRACT

Recent studies have confirmed immunomodulatory and anti-inflammatory properties of probiotics. There are clinical evidences suggesting that probiotics and prebiotics treatment is effective and had a protective effect in the development of atopic dermatitis and the mechanism may be related to local effect on the gastrointestinal tract. About the effect of probiotics on the allergic airway response, the beneficial effects seem to be strain specific, and other studies will be needed to understand the mechanisms involved. Recent data suggests that probiotics may have immunomodulatory effects on vaccine responses, but the significance and clinical relevance of this need to be determined too.


Subject(s)
Dermatitis, Atopic/therapy , Hypersensitivity/therapy , Immunity, Innate/immunology , Oligosaccharides , Probiotics , Animals , Bifidobacterium , Dermatitis, Atopic/immunology , Female , Humans , Hypersensitivity/immunology , Infant , Infant, Newborn , Lactobacillus , Mice , Oligosaccharides/administration & dosage , Oligosaccharides/therapeutic use , Pregnancy , Probiotics/administration & dosage , Probiotics/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL